Transgene Stock Quote TNG - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.116

Bid

1.116

Ask

1.122

Volume

7,596

1.116 Day's Range 1.122

1.00 52 Week Range 1.86

Market Cap

112.753M

Previous Close

1.118

Open

1.12

Last Trade

231

1.116

Last Trade Time

08:38:16

Financial Volume

VWAP

Average Volume (3m)

26,773

Shares Outstanding

100,852,742

Dividend Yield

PE Ratio

-5.06

Earnings Per Share (EPS)

-0.22

Revenue

7.9M

Net Profit

-22.33M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.transgene.fr

Headquarters

Illkirch-graffenstaden, Bas-rhin, Fra

Founded

1970

Transgene SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker TNG. The last closing price for Transgene was 1.12 €. Over the last year, Transgene shares have traded in a share price range of 1.00 € to 1.86 €.

Transgene currently has 100,852,742 shares outstanding. The market capitalization of Transgene is 112.75 € million. Transgene has a price to earnings ratio (PE ratio) of -5.06.

Transgene and BioInvent to Present Poster on Oncolytic Virus, BT-001, at ESMO 2024

Transgene and BioInvent to Present Poster on Oncolytic Virus, BT-001, at ESMO 2024 Strasbourg, France, and Lund, Sweden, July 22, 2024, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech...

Bilan du Contrat de Liquidité avec la Société Natixis Oddo BHF SCA au 30 juin 2024

Bilan du Contrat de Liquidité avec la Société Natixis Oddo BHF SCA au 30 juin 2024 Au titre du contrat de liquidité confié par Transgene à Natixis Oddo BHF SCA, à la date du 30 juin 2024, les...

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2024

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2024 Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2024, the...

Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la tête et du cou

Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la...

Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer

Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer Patient screening and enrollment initiated for...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.016	1.45454545455	1.1	1.122	1.094	23889	1.10996149	DE
4	0.016	1.45454545455	1.1	1.122	1.004	19680	1.0845185	DE
12	-0.148	-11.7088607595	1.264	1.35	1	26773	1.19085827	DE
26	-0.196	-14.9390243902	1.312	1.52	1	32001	1.24298194	DE
52	-0.714	-39.0163934426	1.83	1.86	1	28151	1.38186529	DE
156	-1.114	-49.9551569507	2.23	2.99	1	42282	2.10374141	DE
260	-1.224	-52.3076923077	2.34	3.15	0.81	75908	2.00607241	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 1.34 (94.54%)	14.44M
SERVServe Robotics Inc	$ 10.09 (33.64%)	25.2M
NCPLNetcapital Inc	$ 0.1377 (32.40%)	35.71M
RRRichtech Robotics Inc	$ 1.885 (28.23%)	13.57M
AMIXAutonomix Medical Inc	$ 1.70 (20.57%)	791.5k
HUBCWHub Cyber Security Ltd	$ 0.0121 (-47.39%)	1.67k
XCURExicure Inc	$ 0.3989 (-25.45%)	464.18k
PIRSPieris Pharmaceuticals Inc	$ 6.00 (-17.24%)	11
SNTGSentage Holdings Inc	$ 2.07 (-16.53%)	27.42k
BCBPBCB Bancorp Inc	$ 10.20 (-16.53%)	629
NCPLNetcapital Inc	$ 0.1377 (32.40%)	35.71M
SERVServe Robotics Inc	$ 10.09 (33.64%)	25.2M
MIRAMIRA Pharmaceuticals Inc	$ 1.34 (94.54%)	14.44M
RRRichtech Robotics Inc	$ 1.885 (28.23%)	13.57M
MAXNMaxeon Solar Technologies Ltd	$ 0.2266 (5.10%)	9.99M